Clinical efficacy studies of various unimolecular dual and triple agonists targeting the GLP- 1 receptor, GIP receptor, and glucagon receptor have shown promising results when used alone or in conjunction with approved hypoglycemic medications
11.2 Summary of RCTs In a single double-blind crossover RCT by Carlsten et al
Tirzepatide vs retatrutide reconstitution Retatrutide is a triple agonist (GIP/GLP-1/glucagon), and its reconstitution follows the same general approach
If your periods are irregular, chocolate may help you get your period
Similarly, NAD + levels appear reduced in preclinical models of age-associated diseases, including ataxia-telangiectasia (A-T), mitochondrial myopathies, and Alzheimers disease (AD), and disease-matched clinical samples 114,242,243,244,245,246
Medications that mimic GLP-1 are commonly used to treat type 2 diabetes and support weight management, and they are also being studied for potential benefits in heart health and metabolic aging
